{"gene":"TG_286450","gene_symbol":"GRA5","run_date":"2026-09-08T17:00:01+00:00","timeline":{"discoveries":[{"year":1993,"finding":"GRA5 (P21) is encoded by an intron-less gene of 834 bp and the deduced protein contains a 25-amino-acid N-terminal signal peptide and a second hydrophobic domain consistent with a transmembrane region; ultrastructural studies confirmed association of GRA5 with the parasitophorous vacuole membrane (PVM).","method":"cDNA/genomic cloning, sequencing, peptide microsequencing of native antigen, ultrastructural immunolocalization","journal":"Molecular and biochemical parasitology","confidence":"High","confidence_rationale":"Tier 1 / Strong — protein sequence confirmed by direct peptide microsequencing of native antigen plus ultrastructural localization; foundational structural characterization replicated by subsequent studies","pmids":["8515776"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1993,"finding":"In bradyzoites, GRA5 is specifically targeted to the delimiting membrane of the cyst wall, whereas GRA2 preferentially associates with the ground substance and tubular network, demonstrating selective sorting of dense granule contents after exocytosis.","method":"Immunogold electron microscopy with monoclonal antibodies on tachyzoite and bradyzoite stages","journal":"Experimental parasitology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct ultrastructural localization using immunogold labeling, consistent with multiple subsequent studies","pmids":["8344403"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1996,"finding":"The GRA5 promoter contains repeated motifs (A/TGAGACG) within 156–30 bp upstream of the transcription start site that are critical for promoter activity, as demonstrated by deletion analysis and mutation of these elements; this cis-acting element is shared with GRA1, GRA2, and GRA6 promoters.","method":"Transient transformation with CAT reporter gene, deletion analysis, site-directed mutagenesis of promoter elements","journal":"Molecular microbiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct promoter mutagenesis with quantitative reporter assay; single lab but multiple orthogonal deletions and mutations tested","pmids":["8858595"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1997,"finding":"In sporozoites, GRA5 is the only dense granule protein secreted during host cell invasion into the first parasitophorous vacuole (PV1), becoming associated with the PV1 membrane, whereas GRA1, GRA2, and GRA4 are retained in cytoplasmic granules and not exocytosed during PV1 formation.","method":"Immunofluorescence and immunoelectron microscopy of sporozoite-infected host cells using stage-specific antibodies","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct localization experiment in sporozoites, single lab, single method (immunolocalization)","pmids":["9353039"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1999,"finding":"GRA5 is secreted as a soluble form into the parasitophorous vacuole (PV) lumen and subsequently inserts into the PVM as a transmembrane protein with its N-terminal domain in the host cytoplasm and C-terminus in the vacuole lumen. Deletion of 8 of 18 hydrophobic amino acids in the single transmembrane domain abolished PVM association while maintaining correct dense granule packaging and soluble secretion.","method":"Biochemical fractionation, topology assays (protease protection), transmembrane domain deletion mutagenesis, IFA","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (biochemical fractionation, topology protease protection, deletion mutagenesis) in a single rigorous study","pmids":["10198072"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2001,"finding":"Deletion of gra5 does not affect tachyzoite development, demonstrating that GRA5 is dispensable for the asexual lytic cycle in vitro.","method":"Genetic knockout of gra5, phenotypic analysis of tachyzoite growth","journal":"Molecular and biochemical parasitology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean gene knockout with defined negative phenotypic readout, single lab","pmids":["11522359"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2007,"finding":"GRA5 forms high-molecular-weight oligomeric complexes within the parasite and PV soluble fraction in association with GRA3, GRA6, and GRA7. After membrane insertion, GRA5-HA-FLAG associates only with GRA7 in the PVM, indicating that complex composition changes upon membrane integration.","method":"Affinity purification of HA-FLAG-tagged GRA5 from complemented ΔΔgra knocked-out parasites, conventional chromatography, mass spectrometry identification of co-purified partners","journal":"Molecular and biochemical parasitology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal affinity purification in null-background parasites plus chromatography, two orthogonal approaches, single lab","pmids":["17959262"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2008,"finding":"When GRA5 is expressed in mammalian cells, it inserts into the plasma membrane as a type I integral membrane protein, demonstrating that soluble trafficking of GRA5 in the parasite is parasite-specific. The N-terminal ectodomain of GRA5 was shown to be both necessary to prevent premature membrane integration within the parasite and essential for correct sorting and post-secretory membrane insertion into the vacuolar membrane.","method":"Heterologous expression of GRA5 (and truncation mutants) in mammalian cells, topology assays, IFA, biochemical fractionation","journal":"Traffic (Copenhagen, Denmark)","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution in heterologous system plus domain mutagenesis and topology assays, multiple orthogonal methods in a single study","pmids":["18631244"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2012,"finding":"GRA5 soluble protein and a synthetic peptide (Pep29) derived from its hydrophilic N-terminal region are internalized by human dendritic cells via macropinocytosis and trigger CCR7-dependent migration of CD34-derived dendritic cells toward CCL19 without activating the DCs, and reduce Langerhans cell numbers in human skin epidermis.","method":"In vitro DC migration assay, CCR7 expression analysis, macropinocytosis inhibition assay, human skin epidermal LC depletion assay","journal":"Journal of leukocyte biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional assays with synthetic peptide and recombinant protein, multiple cell-based readouts, single lab","pmids":["23033174"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2019,"finding":"GRA5, as a PVM marker, colocalizes with rat GIMAP4, GIMAP5, and GIMAP6 at the PVM in T. gondii-infected NR8383 macrophage cells, indicating host GIMAPs translocate to the PVM; overexpression of each GIMAP also induced LAMP1 translocation to the parasite surface, implying lysosomal fusion with the otherwise nonfusogenic PVM.","method":"Immunofluorescence colocalization of GFP-tagged GIMAPs with GRA5 (PVM marker), LAMP1 localization assay, intracellular parasite growth inhibition assay","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — GRA5 used as a validated PVM marker; colocalization is indirect evidence; multiple cell-based functional readouts, single lab","pmids":["29378795"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"RH"}]},{"year":2019,"finding":"GRA5, along with GRA2, GRA3, GRA4, GRA7, and GRA12, suppresses MHC-I antigen presentation of PV-localized parasite antigens to CD8+ T cells, as shown by significantly increased antigen presentation in macrophages and/or dendritic cells infected with Δgra5 mutant parasites.","method":"CD8+ T cell antigen presentation assay using Δgra mutant parasites (gra2, gra3, gra4, gra5, gra7, gra12 knockouts) in macrophages and dendritic cells","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockout with defined immunological phenotype readout; multiple GRA deletions tested in parallel; single lab","pmids":["31555296"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2020,"finding":"GRA5 localizes to the cyst membrane and cyst wall region throughout bradyzoite cyst development in vitro, appearing at the cyst periphery as early as 6 h post-differentiation. Δgra5 mutants exhibit a reduced rate of accumulation of cyst wall proteins at the cyst periphery, indicating that PVM-localized GRA5 is required for normal maturation of the cyst wall.","method":"Live imaging and IFA tracking of GRA5 and GRA7 during in vitro differentiation, saponin permeabilization assays, Δgra5 knockout cyst wall protein accumulation analysis","journal":"mSphere","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization tracking over differentiation time course plus genetic knockout with specific cyst wall accumulation phenotype; multiple orthogonal methods, single lab","pmids":["31941814"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2023,"finding":"ME49Δgra5 parasites are avirulent and fail to form tissue cysts in mice, demonstrating that GRA5 is required for cyst formation in the bradyzoite stage. Immunization with ME49Δgra5 conferred complete protection against challenge with type I RH, type II ME49, type III VEG tachyzoites, and ME49 cysts.","method":"CRISPR-based gra5 knockout in ME49 strain, mouse infection/challenge model, cyst burden assessment, cytokine and immune cell phenotyping","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean knockout with in vivo cyst formation phenotype; single lab, multiple readouts","pmids":["37426671"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"ME49"}]}],"current_model":"GRA5 is a dense granule protein that is secreted as a soluble form into the parasitophorous vacuole lumen, where its N-terminal ectodomain prevents premature membrane integration and directs post-secretory insertion as a transmembrane protein (N-terminus facing host cytoplasm, C-terminus in the vacuole lumen) into the PVM; within the parasite and PV soluble fraction it exists in oligomeric complexes with GRA3, GRA6, and GRA7, retaining only a GRA7 association after PVM insertion; GRA5 transitions to the cyst membrane and cyst wall during bradyzoite differentiation where it is required for normal cyst wall maturation and cyst formation in vivo; it also suppresses MHC-I antigen presentation of PV-localized antigens to CD8+ T cells and can modulate dendritic cell migration via its soluble N-terminal domain."},"narrative":{"mechanistic_narrative":"GRA5 is a Toxoplasma gondii dense granule protein that is secreted into the parasitophorous vacuole and functions as a structural component of the vacuolar and cyst membranes across the parasite life cycle [PMID:8515776, PMID:8344403, PMID:10198072]. It is initially secreted as a soluble form into the PV lumen and subsequently inserts into the parasitophorous vacuole membrane (PVM) as a transmembrane protein with its N-terminus facing the host cytoplasm and its C-terminus in the vacuole lumen; deletion within its single hydrophobic transmembrane domain abolishes PVM association without disrupting granule packaging or soluble secretion [PMID:10198072]. Its N-terminal ectodomain is required both to prevent premature membrane integration inside the parasite and to direct correct post-secretory sorting and insertion into the vacuolar membrane, a soluble trafficking behavior that is parasite-specific, since in mammalian cells GRA5 inserts directly into the plasma membrane as a type I integral membrane protein [PMID:18631244]. Within the parasite and PV soluble fraction GRA5 assembles into high-molecular-weight oligomeric complexes with GRA3, GRA6, and GRA7, retaining only an association with GRA7 after PVM insertion [PMID:17959262]. During bradyzoite differentiation GRA5 transitions to the cyst membrane and cyst wall, where it is required for normal cyst wall maturation and, in the ME49 strain, for tissue cyst formation in vivo [PMID:8344403, PMID:31941814, PMID:37426671]. GRA5 also contributes to immune evasion by suppressing MHC-I presentation of PV-localized antigens to CD8+ T cells [PMID:31555296], and its soluble N-terminal domain modulates dendritic cell migration via CCR7 [PMID:23033174]. GRA5 is dispensable for the tachyzoite lytic cycle in vitro [PMID:11522359].","teleology":[{"year":1993,"claim":"Establishing GRA5's primary structure and localization defined it as a PVM-associated dense granule protein with a signal peptide and a transmembrane domain, framing all later trafficking work.","evidence":"cDNA/genomic cloning, peptide microsequencing of native antigen, and ultrastructural immunolocalization in T. gondii","pmids":["8515776"],"confidence":"High","gaps":["Did not resolve membrane topology or the mechanism of PVM insertion","No functional role established"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1993,"claim":"Demonstrating that GRA5 sorts selectively to the cyst-wall delimiting membrane while GRA2 goes to the ground substance showed that dense granule contents are differentially targeted after exocytosis.","evidence":"Immunogold electron microscopy with monoclonal antibodies on tachyzoite and bradyzoite stages","pmids":["8344403"],"confidence":"High","gaps":["Sorting signal responsible for selective targeting not identified","Functional consequence of cyst membrane localization not tested"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1996,"claim":"Identifying shared cis-acting promoter motifs explained how GRA5 is co-regulated with other dense granule genes at the transcriptional level.","evidence":"Transient CAT reporter transformation with promoter deletion and site-directed mutagenesis in T. gondii","pmids":["8858595"],"confidence":"High","gaps":["Trans-acting factors binding the motif not identified","Stage-specific regulation not addressed"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1997,"claim":"Finding GRA5 to be the only dense granule protein secreted into the sporozoite's first PV distinguished its early exocytosis behavior from other GRAs.","evidence":"Immunofluorescence and immunoelectron microscopy of sporozoite-infected host cells with stage-specific antibodies","pmids":["9353039"],"confidence":"Medium","gaps":["Single method (immunolocalization) and single lab","Mechanistic basis for selective sporozoite secretion unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":1999,"claim":"Resolving that GRA5 is secreted soluble and then inserts into the PVM as a transmembrane protein with defined topology established its post-secretory membrane integration mechanism.","evidence":"Biochemical fractionation, protease-protection topology assays, and transmembrane deletion mutagenesis in T. gondii","pmids":["10198072"],"confidence":"High","gaps":["Machinery mediating post-secretory insertion not identified","Signal preventing premature integration not yet mapped"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2001,"claim":"Showing gra5 deletion does not impair tachyzoite growth established that GRA5 is dispensable for the asexual lytic cycle, redirecting attention to non-growth roles.","evidence":"Genetic knockout of gra5 with phenotypic analysis of tachyzoite growth in T. gondii","pmids":["11522359"],"confidence":"Medium","gaps":["Negative in vitro phenotype leaves in vivo and stage-specific roles untested","Single lab"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2007,"claim":"Defining GRA5's oligomeric partners and their change upon membrane insertion revealed that GRA5 acts within multiprotein GRA complexes whose composition is remodeled at the PVM.","evidence":"Affinity purification of tagged GRA5 from null-background parasites, chromatography, and mass spectrometry in T. gondii","pmids":["17959262"],"confidence":"High","gaps":["Stoichiometry and functional role of the complexes not established","Whether GRA7 association is direct not shown"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2008,"claim":"Heterologous expression showed GRA5's soluble trafficking is parasite-specific and mapped the N-terminal ectodomain as the determinant preventing premature integration and directing PVM insertion.","evidence":"Heterologous expression of GRA5 and truncation mutants in mammalian cells with topology and fractionation assays","pmids":["18631244"],"confidence":"High","gaps":["Parasite-specific factor recognizing the ectodomain not identified","Molecular mechanism of insertion still unresolved"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2012,"claim":"Demonstrating that the soluble GRA5 N-terminal domain drives CCR7-dependent dendritic cell migration identified an immunomodulatory function for its ectodomain independent of membrane insertion.","evidence":"In vitro DC migration and macropinocytosis assays and human skin Langerhans cell depletion using recombinant protein and peptide","pmids":["23033174"],"confidence":"Medium","gaps":["Host receptor engaged by the peptide not identified","In vivo relevance during infection not established"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2019,"claim":"Knockout comparisons showed GRA5 among several GRAs suppresses MHC-I presentation of PV antigens to CD8+ T cells, linking GRA5 to immune evasion.","evidence":"CD8+ T cell antigen presentation assays with Δgra mutant parasites in macrophages and dendritic cells","pmids":["31555296"],"confidence":"Medium","gaps":["Molecular mechanism of MHC-I suppression not defined","Individual contribution of GRA5 versus other GRAs not isolated"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2020,"claim":"Tracking GRA5 through bradyzoite differentiation and knockout analysis established that PVM-localized GRA5 is required for normal cyst wall maturation.","evidence":"Live imaging/IFA time course, saponin permeabilization, and Δgra5 cyst wall protein accumulation analysis in T. gondii","pmids":["31941814"],"confidence":"High","gaps":["Mechanism by which GRA5 promotes cyst wall protein accumulation unknown","Direct interactions within the cyst wall not defined"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2023,"claim":"In vivo knockout in ME49 showed GRA5 is required for tissue cyst formation and that Δgra5 confers cross-strain protective immunity, establishing GRA5's role in chronic-stage biology and vaccine potential.","evidence":"CRISPR gra5 knockout in ME49, mouse infection/challenge, cyst burden, and immune phenotyping","pmids":["37426671"],"confidence":"Medium","gaps":["Mechanistic basis for cyst formation failure not defined","Whether protection generalizes beyond mouse model unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":"ME49"}]},{"year":null,"claim":"The parasite-specific machinery that keeps GRA5 soluble in the PV and mediates its post-secretory insertion into the PVM and cyst membrane remains unidentified.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No trans-acting factor recognizing the N-terminal ectodomain identified","Mechanism connecting PVM insertion to cyst wall maturation unresolved","Molecular basis of MHC-I suppression unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":["GRA5-GRA3-GRA6-GRA7 oligomeric complex in parasite and PV soluble fraction [#6]","GRA5-GRA7 complex at the PVM [#6]"],"partners":["GRA3 [#6]","GRA6 [#6]","GRA7 [#6]"],"other_free_text":["Secreted as soluble form into PV lumen, then post-secretorily inserts into PVM as transmembrane protein (N-terminus host cytoplasm, C-terminus vacuole lumen) [#4]","N-terminal ectodomain prevents premature membrane integration and directs correct sorting/insertion [#7]","Soluble N-terminal domain/Pep29 internalized by dendritic cells via macropinocytosis and drives CCR7-dependent DC migration [#8]","GRA5 promoter contains repeated A/TGAGACG motifs shared with GRA1, GRA2, GRA6 that are required for promoter activity [#2]","Dispensable for tachyzoite lytic cycle in vitro [#5]","Required for cyst wall maturation and (ME49) tissue cyst formation in vivo; Δgra5 immunization confers cross-strain protection [#11, #12]","Used as a validated PVM marker; host GIMAP4/5/6 colocalize with GRA5 at the PVM [#9]"]},"strain_conflicts":[]},"prefetch_data":{},"corpus_meta":[{"pmid":"12455982","id":"PMC_12455982","title":"Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expression.","date":"2002","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/12455982","citation_count":131,"is_preprint":false},{"pmid":"19638313","id":"PMC_19638313","title":"Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring.","date":"2009","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/19638313","citation_count":107,"is_preprint":false},{"pmid":"16938480","id":"PMC_16938480","title":"Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America).","date":"2006","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/16938480","citation_count":92,"is_preprint":false},{"pmid":"10198072","id":"PMC_10198072","title":"Transmembrane insertion of the Toxoplasma gondii GRA5 protein occurs after soluble secretion into the host cell.","date":"1999","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/10198072","citation_count":82,"is_preprint":false},{"pmid":"7637717","id":"PMC_7637717","title":"Characterization of a dense granule antigen of Toxoplasma gondii (GRA6) associated to the network of the parasitophorous vacuole.","date":"1995","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/7637717","citation_count":79,"is_preprint":false},{"pmid":"8515776","id":"PMC_8515776","title":"Molecular structure of a Toxoplasma gondii dense granule antigen (GRA 5) associated with the parasitophorous vacuole membrane.","date":"1993","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/8515776","citation_count":77,"is_preprint":false},{"pmid":"31040239","id":"PMC_31040239","title":"Enrichment and Proteomic Characterization of the Cyst Wall from In Vitro Toxoplasma gondii Cysts.","date":"2019","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/31040239","citation_count":65,"is_preprint":false},{"pmid":"10320624","id":"PMC_10320624","title":"Protective immunity in the rat model of congenital toxoplasmosis and the potential of excreted-secreted antigens as vaccine components.","date":"1999","source":"Parasite immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10320624","citation_count":64,"is_preprint":false},{"pmid":"27199938","id":"PMC_27199938","title":"Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB/c Mice.","date":"2016","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/27199938","citation_count":52,"is_preprint":false},{"pmid":"18539501","id":"PMC_18539501","title":"Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America.","date":"2008","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/18539501","citation_count":52,"is_preprint":false},{"pmid":"9353039","id":"PMC_9353039","title":"Toxoplasma gondii sporozoites form a transient parasitophorous vacuole that is impermeable and contains only a subset of dense-granule proteins.","date":"1997","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9353039","citation_count":51,"is_preprint":false},{"pmid":"8858595","id":"PMC_8858595","title":"Common cis-acting elements critical for the expression of several genes of Toxoplasma gondii.","date":"1996","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/8858595","citation_count":46,"is_preprint":false},{"pmid":"8344403","id":"PMC_8344403","title":"Toxoplasma gondii: differential location of antigens secreted from encysted bradyzoites.","date":"1993","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/8344403","citation_count":45,"is_preprint":false},{"pmid":"23206419","id":"PMC_23206419","title":"Genetic diversity among Toxoplasma gondii strains from different hosts and geographical regions revealed by sequence analysis of GRA5 gene.","date":"2012","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/23206419","citation_count":40,"is_preprint":false},{"pmid":"19874823","id":"PMC_19874823","title":"Toxoplasma gondii: Recombinant GRA5 antigen for detection of immunoglobulin G antibodies using enzyme-linked immunosorbent assay.","date":"2009","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/19874823","citation_count":40,"is_preprint":false},{"pmid":"17959262","id":"PMC_17959262","title":"Purification of Toxoplasma dense granule proteins reveals that they are in complexes throughout the secretory pathway.","date":"2007","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/17959262","citation_count":36,"is_preprint":false},{"pmid":"31941814","id":"PMC_31941814","title":"Toxoplasma gondii Parasitophorous Vacuole Membrane-Associated Dense Granule Proteins Regulate Maturation of the Cyst Wall.","date":"2020","source":"mSphere","url":"https://pubmed.ncbi.nlm.nih.gov/31941814","citation_count":26,"is_preprint":false},{"pmid":"18631244","id":"PMC_18631244","title":"Toxoplasma gondii uses unusual sorting mechanisms to deliver transmembrane proteins into the host-cell vacuole.","date":"2008","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/18631244","citation_count":26,"is_preprint":false},{"pmid":"29973272","id":"PMC_29973272","title":"Discovery of new Toxoplasma gondii antigenic proteins using a high throughput protein microarray approach screening sera of murine model infected orally with oocysts and tissue cysts.","date":"2018","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/29973272","citation_count":24,"is_preprint":false},{"pmid":"8740550","id":"PMC_8740550","title":"Toxoplasma gondii: appearance of specific markers during the development of tissue cysts in vitro.","date":"1996","source":"Parasitology research","url":"https://pubmed.ncbi.nlm.nih.gov/8740550","citation_count":22,"is_preprint":false},{"pmid":"31555296","id":"PMC_31555296","title":"Rhoptry and Dense Granule Secreted Effectors Regulate CD8+ T Cell Recognition of Toxoplasma gondii Infected Host Cells.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31555296","citation_count":21,"is_preprint":false},{"pmid":"25586591","id":"PMC_25586591","title":"Identification of Toxoplasma gondii antigens associated with different types of infection by serum antibody profiling.","date":"2015","source":"Parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/25586591","citation_count":21,"is_preprint":false},{"pmid":"25300561","id":"PMC_25300561","title":"The optimal mixture of Toxoplasma gondii recombinant antigens (GRA1, P22, ROP1) for diagnosis of ovine toxoplasmosis.","date":"2014","source":"Veterinary parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/25300561","citation_count":20,"is_preprint":false},{"pmid":"26811726","id":"PMC_26811726","title":"Evaluation of Immunogenicity of Cocktail DNA Vaccine Containing Plasmids Encoding Complete GRA5, SAG1, and ROP2 Antigens of Toxoplasma gondii in BALB/C Mice.","date":"2015","source":"Iranian journal of parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/26811726","citation_count":19,"is_preprint":false},{"pmid":"25178555","id":"PMC_25178555","title":"Prevalence and molecular characterizations of Toxoplasma gondii and Babesia microti from small mammals captured in Gyeonggi and Gangwon Provinces, Republic of Korea.","date":"2014","source":"Veterinary parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/25178555","citation_count":18,"is_preprint":false},{"pmid":"11522359","id":"PMC_11522359","title":"Lack of expression of the dense granule protein GRA5 does not affect the development of Toxoplasma tachyzoites.","date":"2001","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/11522359","citation_count":15,"is_preprint":false},{"pmid":"29378795","id":"PMC_29378795","title":"Small GTPase Immunity-Associated Proteins Mediate Resistance to Toxoplasma gondii Infection in Lewis Rat.","date":"2018","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/29378795","citation_count":15,"is_preprint":false},{"pmid":"23033174","id":"PMC_23033174","title":"A synthetic peptide derived from the parasite Toxoplasma gondii triggers human dendritic cells' migration.","date":"2012","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/23033174","citation_count":15,"is_preprint":false},{"pmid":"34055664","id":"PMC_34055664","title":"Comparative Proteomics Analysis for Elucidating the Interaction Between Host Cells and Toxoplasma gondii.","date":"2021","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34055664","citation_count":14,"is_preprint":false},{"pmid":"16213182","id":"PMC_16213182","title":"The Toxoplasma surface protein SAG1 triggers efficient in vitro secretion of chemokine ligand 2 (CCL2) from human fibroblasts.","date":"2005","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/16213182","citation_count":14,"is_preprint":false},{"pmid":"37426671","id":"PMC_37426671","title":"Toxoplasma gondii gra5 deletion mutant protects hosts against Toxoplasma gondii infection and breast tumors.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37426671","citation_count":13,"is_preprint":false},{"pmid":"28719288","id":"PMC_28719288","title":"Evaluation of the Protective Effect of Deoxyribonucleic Acid Vaccines Encoding Granule Antigen 2 and 5 Against Acute Toxoplasmosis in BALB/c Mice.","date":"2017","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/28719288","citation_count":11,"is_preprint":false},{"pmid":"33680990","id":"PMC_33680990","title":"Toxoplasma GRA Peptide-Specific Serologic Fingerprints Discriminate Among Major Strains Causing Toxoplasmosis.","date":"2021","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/33680990","citation_count":10,"is_preprint":false},{"pmid":"33242641","id":"PMC_33242641","title":"Engineering an efficient poly-epitope vaccine against Toxoplasma gondii infection: A computational vaccinology study.","date":"2020","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/33242641","citation_count":10,"is_preprint":false},{"pmid":"24987700","id":"PMC_24987700","title":"Recombinant dense granular protein (GRA5) for detection of human toxoplasmosis by Western blot.","date":"2014","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/24987700","citation_count":9,"is_preprint":false},{"pmid":"38576040","id":"PMC_38576040","title":"Trx4, a novel thioredoxin protein, is important for Toxoplasma gondii fitness.","date":"2024","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/38576040","citation_count":8,"is_preprint":false},{"pmid":"38673969","id":"PMC_38673969","title":"The Development of Toxoplasma gondii Recombinant Trivalent Chimeric Proteins as an Alternative to Toxoplasma Lysate Antigen (TLA) in Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Immunoglobulin G (IgG) in Small Ruminants.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38673969","citation_count":8,"is_preprint":false},{"pmid":"33939858","id":"PMC_33939858","title":"Immunodiagnosis and molecular validation of Toxoplasma gondii-recombinant dense granular (GRA) 5 protein for the detection of toxoplasmosis in hemodialysis patients.","date":"2021","source":"Seminars in dialysis","url":"https://pubmed.ncbi.nlm.nih.gov/33939858","citation_count":7,"is_preprint":false},{"pmid":"18551396","id":"PMC_18551396","title":"Toxoplasma gondii: cloning, sequencing, expression, and antigenic characterization of ROP2, GRA5 and GRA7.","date":"2008","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/18551396","citation_count":6,"is_preprint":false},{"pmid":"28149494","id":"PMC_28149494","title":"Cloning, expression and immunoreactivity of recombinant Toxoplasma gondii GRA5 protein.","date":"2016","source":"Iranian journal of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28149494","citation_count":5,"is_preprint":false},{"pmid":"36403800","id":"PMC_36403800","title":"Immunological evaluation of a novel multi-antigenic DNA vaccine encoding SAG1, SAG3, MIC4, GRA5, GRA7, AMA1and BAG1 against Toxoplasma gondii in BALB/c mice.","date":"2022","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/36403800","citation_count":5,"is_preprint":false},{"pmid":"26521511","id":"PMC_26521511","title":"HETEROLOGOUS EXPRESSION OF TOXOPLASMA GONDII DENSE GRANULE PROTEIN 2 AND 5.","date":"2015","source":"The Southeast Asian journal of tropical medicine and public health","url":"https://pubmed.ncbi.nlm.nih.gov/26521511","citation_count":4,"is_preprint":false},{"pmid":"24646180","id":"PMC_24646180","title":"Identification of genes expressed during Toxoplasma gondii infection by in vivo-induced antigen technology (IVIAT) with positive porcine sera.","date":"2014","source":"The Journal of parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/24646180","citation_count":4,"is_preprint":false},{"pmid":"40872874","id":"PMC_40872874","title":"Protective Efficacy Induced by Virus-like Particles Expressing Dense Granule Protein 5 of Toxoplasma gondii.","date":"2025","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/40872874","citation_count":3,"is_preprint":false},{"pmid":"38720960","id":"PMC_38720960","title":"A combination of GRA3, GRA6 and GRA7 peptides offer a useful tool for serotyping type II and III Toxoplasma gondii infections in sheep and pigs.","date":"2024","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/38720960","citation_count":3,"is_preprint":false},{"pmid":"40429830","id":"PMC_40429830","title":"A Structural In Silico Analysis of Novel Epitopes from Toxoplasma gondii Proteins for the Serodiagnosis of Toxoplasmosis.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40429830","citation_count":2,"is_preprint":false},{"pmid":"23407179","id":"PMC_23407179","title":"Construction and In vitro Expression Analyses of a DNA Plasmid Encoding Dense Granule GRA5 Antigen of Toxoplasma gondii.","date":"2011","source":"Avicenna journal of medical biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/23407179","citation_count":1,"is_preprint":false},{"pmid":"42252477","id":"PMC_42252477","title":"Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers.","date":"2026","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/42252477","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":26780,"output_tokens":3567,"usd":0.066922,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9686,"output_tokens":4726,"usd":0.08329,"stage2_stop_reason":"end_turn"},"total_usd":0.0,"stage1_batch_id":"msgbatch_01XFXJD6iZecXyWn9uU5Qom9","stage2_batch_id":"msgbatch_013GToKgs4AKSCRE4yvueviH","note":"batch pricing = 50% of standard","skipped":true},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"GRA5 (P21) is encoded by an intron-less gene of 834 bp and the deduced protein contains a 25-amino-acid N-terminal signal peptide and a second hydrophobic domain consistent with a transmembrane region; ultrastructural studies confirmed association of GRA5 with the parasitophorous vacuole membrane (PVM).\",\n      \"method\": \"cDNA/genomic cloning, sequencing, peptide microsequencing of native antigen, ultrastructural immunolocalization\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — protein sequence confirmed by direct peptide microsequencing of native antigen plus ultrastructural localization; foundational structural characterization replicated by subsequent studies\",\n      \"pmids\": [\"8515776\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"In bradyzoites, GRA5 is specifically targeted to the delimiting membrane of the cyst wall, whereas GRA2 preferentially associates with the ground substance and tubular network, demonstrating selective sorting of dense granule contents after exocytosis.\",\n      \"method\": \"Immunogold electron microscopy with monoclonal antibodies on tachyzoite and bradyzoite stages\",\n      \"journal\": \"Experimental parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct ultrastructural localization using immunogold labeling, consistent with multiple subsequent studies\",\n      \"pmids\": [\"8344403\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The GRA5 promoter contains repeated motifs (A/TGAGACG) within 156–30 bp upstream of the transcription start site that are critical for promoter activity, as demonstrated by deletion analysis and mutation of these elements; this cis-acting element is shared with GRA1, GRA2, and GRA6 promoters.\",\n      \"method\": \"Transient transformation with CAT reporter gene, deletion analysis, site-directed mutagenesis of promoter elements\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct promoter mutagenesis with quantitative reporter assay; single lab but multiple orthogonal deletions and mutations tested\",\n      \"pmids\": [\"8858595\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"In sporozoites, GRA5 is the only dense granule protein secreted during host cell invasion into the first parasitophorous vacuole (PV1), becoming associated with the PV1 membrane, whereas GRA1, GRA2, and GRA4 are retained in cytoplasmic granules and not exocytosed during PV1 formation.\",\n      \"method\": \"Immunofluorescence and immunoelectron microscopy of sporozoite-infected host cells using stage-specific antibodies\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct localization experiment in sporozoites, single lab, single method (immunolocalization)\",\n      \"pmids\": [\"9353039\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GRA5 is secreted as a soluble form into the parasitophorous vacuole (PV) lumen and subsequently inserts into the PVM as a transmembrane protein with its N-terminal domain in the host cytoplasm and C-terminus in the vacuole lumen. Deletion of 8 of 18 hydrophobic amino acids in the single transmembrane domain abolished PVM association while maintaining correct dense granule packaging and soluble secretion.\",\n      \"method\": \"Biochemical fractionation, topology assays (protease protection), transmembrane domain deletion mutagenesis, IFA\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (biochemical fractionation, topology protease protection, deletion mutagenesis) in a single rigorous study\",\n      \"pmids\": [\"10198072\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Deletion of gra5 does not affect tachyzoite development, demonstrating that GRA5 is dispensable for the asexual lytic cycle in vitro.\",\n      \"method\": \"Genetic knockout of gra5, phenotypic analysis of tachyzoite growth\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean gene knockout with defined negative phenotypic readout, single lab\",\n      \"pmids\": [\"11522359\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GRA5 forms high-molecular-weight oligomeric complexes within the parasite and PV soluble fraction in association with GRA3, GRA6, and GRA7. After membrane insertion, GRA5-HA-FLAG associates only with GRA7 in the PVM, indicating that complex composition changes upon membrane integration.\",\n      \"method\": \"Affinity purification of HA-FLAG-tagged GRA5 from complemented ΔΔgra knocked-out parasites, conventional chromatography, mass spectrometry identification of co-purified partners\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal affinity purification in null-background parasites plus chromatography, two orthogonal approaches, single lab\",\n      \"pmids\": [\"17959262\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"When GRA5 is expressed in mammalian cells, it inserts into the plasma membrane as a type I integral membrane protein, demonstrating that soluble trafficking of GRA5 in the parasite is parasite-specific. The N-terminal ectodomain of GRA5 was shown to be both necessary to prevent premature membrane integration within the parasite and essential for correct sorting and post-secretory membrane insertion into the vacuolar membrane.\",\n      \"method\": \"Heterologous expression of GRA5 (and truncation mutants) in mammalian cells, topology assays, IFA, biochemical fractionation\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution in heterologous system plus domain mutagenesis and topology assays, multiple orthogonal methods in a single study\",\n      \"pmids\": [\"18631244\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GRA5 soluble protein and a synthetic peptide (Pep29) derived from its hydrophilic N-terminal region are internalized by human dendritic cells via macropinocytosis and trigger CCR7-dependent migration of CD34-derived dendritic cells toward CCL19 without activating the DCs, and reduce Langerhans cell numbers in human skin epidermis.\",\n      \"method\": \"In vitro DC migration assay, CCR7 expression analysis, macropinocytosis inhibition assay, human skin epidermal LC depletion assay\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional assays with synthetic peptide and recombinant protein, multiple cell-based readouts, single lab\",\n      \"pmids\": [\"23033174\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GRA5, as a PVM marker, colocalizes with rat GIMAP4, GIMAP5, and GIMAP6 at the PVM in T. gondii-infected NR8383 macrophage cells, indicating host GIMAPs translocate to the PVM; overexpression of each GIMAP also induced LAMP1 translocation to the parasite surface, implying lysosomal fusion with the otherwise nonfusogenic PVM.\",\n      \"method\": \"Immunofluorescence colocalization of GFP-tagged GIMAPs with GRA5 (PVM marker), LAMP1 localization assay, intracellular parasite growth inhibition assay\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — GRA5 used as a validated PVM marker; colocalization is indirect evidence; multiple cell-based functional readouts, single lab\",\n      \"pmids\": [\"29378795\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"RH\"}]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GRA5, along with GRA2, GRA3, GRA4, GRA7, and GRA12, suppresses MHC-I antigen presentation of PV-localized parasite antigens to CD8+ T cells, as shown by significantly increased antigen presentation in macrophages and/or dendritic cells infected with Δgra5 mutant parasites.\",\n      \"method\": \"CD8+ T cell antigen presentation assay using Δgra mutant parasites (gra2, gra3, gra4, gra5, gra7, gra12 knockouts) in macrophages and dendritic cells\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout with defined immunological phenotype readout; multiple GRA deletions tested in parallel; single lab\",\n      \"pmids\": [\"31555296\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRA5 localizes to the cyst membrane and cyst wall region throughout bradyzoite cyst development in vitro, appearing at the cyst periphery as early as 6 h post-differentiation. Δgra5 mutants exhibit a reduced rate of accumulation of cyst wall proteins at the cyst periphery, indicating that PVM-localized GRA5 is required for normal maturation of the cyst wall.\",\n      \"method\": \"Live imaging and IFA tracking of GRA5 and GRA7 during in vitro differentiation, saponin permeabilization assays, Δgra5 knockout cyst wall protein accumulation analysis\",\n      \"journal\": \"mSphere\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization tracking over differentiation time course plus genetic knockout with specific cyst wall accumulation phenotype; multiple orthogonal methods, single lab\",\n      \"pmids\": [\"31941814\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ME49Δgra5 parasites are avirulent and fail to form tissue cysts in mice, demonstrating that GRA5 is required for cyst formation in the bradyzoite stage. Immunization with ME49Δgra5 conferred complete protection against challenge with type I RH, type II ME49, type III VEG tachyzoites, and ME49 cysts.\",\n      \"method\": \"CRISPR-based gra5 knockout in ME49 strain, mouse infection/challenge model, cyst burden assessment, cytokine and immune cell phenotyping\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout with in vivo cyst formation phenotype; single lab, multiple readouts\",\n      \"pmids\": [\"37426671\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"ME49\"}]\n    }\n  ],\n  \"current_model\": \"GRA5 is a dense granule protein that is secreted as a soluble form into the parasitophorous vacuole lumen, where its N-terminal ectodomain prevents premature membrane integration and directs post-secretory insertion as a transmembrane protein (N-terminus facing host cytoplasm, C-terminus in the vacuole lumen) into the PVM; within the parasite and PV soluble fraction it exists in oligomeric complexes with GRA3, GRA6, and GRA7, retaining only a GRA7 association after PVM insertion; GRA5 transitions to the cyst membrane and cyst wall during bradyzoite differentiation where it is required for normal cyst wall maturation and cyst formation in vivo; it also suppresses MHC-I antigen presentation of PV-localized antigens to CD8+ T cells and can modulate dendritic cell migration via its soluble N-terminal domain.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GRA5 is a Toxoplasma gondii dense granule protein that is secreted into the parasitophorous vacuole and functions as a structural component of the vacuolar and cyst membranes across the parasite life cycle [#0, #1, #4]. It is initially secreted as a soluble form into the PV lumen and subsequently inserts into the parasitophorous vacuole membrane (PVM) as a transmembrane protein with its N-terminus facing the host cytoplasm and its C-terminus in the vacuole lumen; deletion within its single hydrophobic transmembrane domain abolishes PVM association without disrupting granule packaging or soluble secretion [#4]. Its N-terminal ectodomain is required both to prevent premature membrane integration inside the parasite and to direct correct post-secretory sorting and insertion into the vacuolar membrane, a soluble trafficking behavior that is parasite-specific, since in mammalian cells GRA5 inserts directly into the plasma membrane as a type I integral membrane protein [#7]. Within the parasite and PV soluble fraction GRA5 assembles into high-molecular-weight oligomeric complexes with GRA3, GRA6, and GRA7, retaining only an association with GRA7 after PVM insertion [#6]. During bradyzoite differentiation GRA5 transitions to the cyst membrane and cyst wall, where it is required for normal cyst wall maturation and, in the ME49 strain, for tissue cyst formation in vivo [#1, #11, #12]. GRA5 also contributes to immune evasion by suppressing MHC-I presentation of PV-localized antigens to CD8+ T cells [#10], and its soluble N-terminal domain modulates dendritic cell migration via CCR7 [#8]. GRA5 is dispensable for the tachyzoite lytic cycle in vitro [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Establishing GRA5's primary structure and localization defined it as a PVM-associated dense granule protein with a signal peptide and a transmembrane domain, framing all later trafficking work.\",\n      \"evidence\": \"cDNA/genomic cloning, peptide microsequencing of native antigen, and ultrastructural immunolocalization in T. gondii\",\n      \"pmids\": [\"8515776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve membrane topology or the mechanism of PVM insertion\", \"No functional role established\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Demonstrating that GRA5 sorts selectively to the cyst-wall delimiting membrane while GRA2 goes to the ground substance showed that dense granule contents are differentially targeted after exocytosis.\",\n      \"evidence\": \"Immunogold electron microscopy with monoclonal antibodies on tachyzoite and bradyzoite stages\",\n      \"pmids\": [\"8344403\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Sorting signal responsible for selective targeting not identified\", \"Functional consequence of cyst membrane localization not tested\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identifying shared cis-acting promoter motifs explained how GRA5 is co-regulated with other dense granule genes at the transcriptional level.\",\n      \"evidence\": \"Transient CAT reporter transformation with promoter deletion and site-directed mutagenesis in T. gondii\",\n      \"pmids\": [\"8858595\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting factors binding the motif not identified\", \"Stage-specific regulation not addressed\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Finding GRA5 to be the only dense granule protein secreted into the sporozoite's first PV distinguished its early exocytosis behavior from other GRAs.\",\n      \"evidence\": \"Immunofluorescence and immunoelectron microscopy of sporozoite-infected host cells with stage-specific antibodies\",\n      \"pmids\": [\"9353039\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single method (immunolocalization) and single lab\", \"Mechanistic basis for selective sporozoite secretion unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Resolving that GRA5 is secreted soluble and then inserts into the PVM as a transmembrane protein with defined topology established its post-secretory membrane integration mechanism.\",\n      \"evidence\": \"Biochemical fractionation, protease-protection topology assays, and transmembrane deletion mutagenesis in T. gondii\",\n      \"pmids\": [\"10198072\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Machinery mediating post-secretory insertion not identified\", \"Signal preventing premature integration not yet mapped\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showing gra5 deletion does not impair tachyzoite growth established that GRA5 is dispensable for the asexual lytic cycle, redirecting attention to non-growth roles.\",\n      \"evidence\": \"Genetic knockout of gra5 with phenotypic analysis of tachyzoite growth in T. gondii\",\n      \"pmids\": [\"11522359\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Negative in vitro phenotype leaves in vivo and stage-specific roles untested\", \"Single lab\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defining GRA5's oligomeric partners and their change upon membrane insertion revealed that GRA5 acts within multiprotein GRA complexes whose composition is remodeled at the PVM.\",\n      \"evidence\": \"Affinity purification of tagged GRA5 from null-background parasites, chromatography, and mass spectrometry in T. gondii\",\n      \"pmids\": [\"17959262\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and functional role of the complexes not established\", \"Whether GRA7 association is direct not shown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Heterologous expression showed GRA5's soluble trafficking is parasite-specific and mapped the N-terminal ectodomain as the determinant preventing premature integration and directing PVM insertion.\",\n      \"evidence\": \"Heterologous expression of GRA5 and truncation mutants in mammalian cells with topology and fractionation assays\",\n      \"pmids\": [\"18631244\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Parasite-specific factor recognizing the ectodomain not identified\", \"Molecular mechanism of insertion still unresolved\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrating that the soluble GRA5 N-terminal domain drives CCR7-dependent dendritic cell migration identified an immunomodulatory function for its ectodomain independent of membrane insertion.\",\n      \"evidence\": \"In vitro DC migration and macropinocytosis assays and human skin Langerhans cell depletion using recombinant protein and peptide\",\n      \"pmids\": [\"23033174\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Host receptor engaged by the peptide not identified\", \"In vivo relevance during infection not established\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Knockout comparisons showed GRA5 among several GRAs suppresses MHC-I presentation of PV antigens to CD8+ T cells, linking GRA5 to immune evasion.\",\n      \"evidence\": \"CD8+ T cell antigen presentation assays with Δgra mutant parasites in macrophages and dendritic cells\",\n      \"pmids\": [\"31555296\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of MHC-I suppression not defined\", \"Individual contribution of GRA5 versus other GRAs not isolated\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Tracking GRA5 through bradyzoite differentiation and knockout analysis established that PVM-localized GRA5 is required for normal cyst wall maturation.\",\n      \"evidence\": \"Live imaging/IFA time course, saponin permeabilization, and Δgra5 cyst wall protein accumulation analysis in T. gondii\",\n      \"pmids\": [\"31941814\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which GRA5 promotes cyst wall protein accumulation unknown\", \"Direct interactions within the cyst wall not defined\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"In vivo knockout in ME49 showed GRA5 is required for tissue cyst formation and that Δgra5 confers cross-strain protective immunity, establishing GRA5's role in chronic-stage biology and vaccine potential.\",\n      \"evidence\": \"CRISPR gra5 knockout in ME49, mouse infection/challenge, cyst burden, and immune phenotyping\",\n      \"pmids\": [\"37426671\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic basis for cyst formation failure not defined\", \"Whether protection generalizes beyond mouse model unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"ME49\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The parasite-specific machinery that keeps GRA5 soluble in the PV and mediates its post-secretory insertion into the PVM and cyst membrane remains unidentified.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No trans-acting factor recognizing the N-terminal ectodomain identified\", \"Mechanism connecting PVM insertion to cyst wall maturation unresolved\", \"Molecular basis of MHC-I suppression unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016020\", \"supporting_discovery_ids\": [4, 7], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0042803\", \"supporting_discovery_ids\": [6], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020003\", \"supporting_discovery_ids\": [0, 4], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0020005\", \"supporting_discovery_ids\": [0, 4, 7], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0020026\", \"supporting_discovery_ids\": [1, 11], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0052572\", \"supporting_discovery_ids\": [10], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"complexes\": [\n      \"GRA5-GRA3-GRA6-GRA7 oligomeric complex in parasite and PV soluble fraction [#6]\",\n      \"GRA5-GRA7 complex at the PVM [#6]\"\n    ],\n    \"partners\": [\n      \"GRA3 [#6]\",\n      \"GRA6 [#6]\",\n      \"GRA7 [#6]\"\n    ],\n    \"other_free_text\": [\n      \"Secreted as soluble form into PV lumen, then post-secretorily inserts into PVM as transmembrane protein (N-terminus host cytoplasm, C-terminus vacuole lumen) [#4]\",\n      \"N-terminal ectodomain prevents premature membrane integration and directs correct sorting/insertion [#7]\",\n      \"Soluble N-terminal domain/Pep29 internalized by dendritic cells via macropinocytosis and drives CCR7-dependent DC migration [#8]\",\n      \"GRA5 promoter contains repeated A/TGAGACG motifs shared with GRA1, GRA2, GRA6 that are required for promoter activity [#2]\",\n      \"Dispensable for tachyzoite lytic cycle in vitro [#5]\",\n      \"Required for cyst wall maturation and (ME49) tissue cyst formation in vivo; Δgra5 immunization confers cross-strain protection [#11, #12]\",\n      \"Used as a validated PVM marker; host GIMAP4/5/6 colocalize with GRA5 at the PVM [#9]\"\n    ]\n  },\n  \"strain_conflicts\": []\n}","audit_flag":null,"strains":[{"strain":"ME49","gene_id":"TGME49_286450","name":"GRA5","product":"dense granule protein GRA5","uniprot_acc":"S8GGQ5","chromosome":"TGME49_chrV","start_pos":1824587},{"strain":"GT1","gene_id":"TGGT1_286450","name":null,"product":"dense granule protein GRA5","uniprot_acc":null,"chromosome":"TGGT1_chrV","start_pos":1680404},{"strain":"RH88","gene_id":"TGRH88_025740","name":null,"product":"dense granule protein GRA5","uniprot_acc":null,"chromosome":"CM023086","start_pos":1858308},{"strain":"VEG","gene_id":"TGVEG_286450","name":null,"product":"dense granule protein GRA5","uniprot_acc":"A0A0F7UV78","chromosome":"TGVEG_chrV","start_pos":1779551}]}